Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ajooni Biotech Limited Capital/Financing Update 2021

Mar 13, 2021

62322_rns_2021-03-13_e676505a-e4f3-4606-b7a2-7718563dffa8.PDF

Capital/Financing Update

Open in viewer

Opens in your device viewer

ONI BIOTECH LIMITED

Regd. Office: D-118, Industrial Area, Phase-VII, Mohali-160055 (Pb.) Phone: 0172-5020758-69 Website: www.ajoonibiotech.com E-mail: [email protected] / [email protected] CIN: L85190PB2010PLC040162

Date: 13/03/2021

To, EMERGE PLATFORM OF NSE National Stock Exchange of India Ltd Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400051

Dear Sir / Madam,

Subject: Outcome of the Board Meeting held on Saturday, 13th March 2021, pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015.

SYMBOL: AJOONI

With reference to the above captioned subject, this to inform you that the Board of Directors of the Company at their meeting held on Saturday, 13th March 2021 at 03.30 p.m concluded at 04:00 p.m. Following transactions were considered and approved:

    1. Considered and approved allotment of 1000558 Bonus equity shares of face Value of Rs. 10/- each to the members holding shares as on the Record date i.e. 12th March 2021.
    1. Considered and approved the appointment of M/s. M R Chechi & Associates, Company Secretaries, Chandigarh as Secretarial Auditor of the company for F.Y. 2020-2021.

You are requested to kindly take the same on your record and acknowledge receipt.

Thanking You, Yours Truly, For Ajooni Biotech Limited $+4$ MOHALI Jasjot Singh Managing Director DIN: 01937631